The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Mhd Yaser Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg A. Bjarnason, Lori Wood, Ulka N. Vaishampayan, Mary J. MacKenzie, Jennifer J. Knox, Neeraj Agarwal, Hulayel Alharbi, Christian Kollmannsberger, Min-Han Tan, Sun Young Rha, Frede Donskov, Scott North, Toni K. Choueiri, Daniel Y.C. Heng
Materiálatiipa: Artigo
Giella:eaŋgalasgiella
Almmustuhtton: 2013
Liŋkkat:https://doi.org/10.1007/s11523-012-0252-7
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

https://doi.org/10.1007/s11523-012-0252-7

Geahča maid